Abstract. Semiconductor quantum dots are tiny light-emitting nanocrystals (2-10 nm) that have captivated researchers in the biomedical field in the last decade. Compared to organic dyes and fluorescent proteins, quantum dots (QDs) have unique optical properties such as tunable emission spectra, improved brightness, superior photostability, and simultaneous excitation of multiple fluorescence colors. Since the first successful reports on biological use of QDs a decade ago, QDs and their bioconjugates have been successfully applied in various imaging applications including fixed cell labeling, imaging of live cell dynamics, in situ tissue profiling, fluorescence detection, sensing and in vivo animal imaging. In this review, we will cover the optical properties of QDs, the biofunctionization strategies, their in vitro diagnostic applications and in vivo imaging applications. In addition, we will discuss the making of a new class of QDs -the self-illuminating QDs and their in vivo imaging and sensing applications. We will conclude with the issues and perspectives on QDs as in vivo imaging probes.
Introduction
The development of a wide spectrum of nanoscale technologies is beginning to change the foundations of disease diagnosis, treatment, and prevention. These technological innovations, referred to as nanomedicine by the National Institutes of Health (Bethesda, MD, USA), have great potentials to lead to major advances in disease detection, diagnosis, and treatment and eventually personalized therapy and disease management. The basic rationale is that metal, semiconductor, and polymeric nanoparticles possess novel optical, electronic, magnetic, and structural properties that are often not available from single individual molecules or bulk solids [1] . Recent research has developed functional nanoparticles that are covalently linked to biological molecules such as peptides, proteins, nucleic acids, or small-molecule ligands [2] [3] [4] . Medical applications have also emerged, such as the use of superparamag-netic iron oxide nanoparticles as a contrast agent for lymph node prostate cancer detection [5] and the use of polymeric nanoparticles for targeted gene delivery to tumor vasculatures [6] . In this review, we will focus on the use of semiconductor quantum dots for in vitro diagnostics and in vivo animal imaging.
QDs are light-emitting semiconductor nanorystals with novel optical and electrical properties. Compared with organic dyes and fluorescent proteins, semiconductor QDs offer several unique advantages, such as size-and composition-tunable emission from visible to infrared wavelengths, large absorption coefficients across a wide spectral range, and very high levels of brightness and photostability [7] . By far, QDs have found applications ranging from bioanalytical assays, to live cell imaging, fixed cell and tissue labeling, biosensors and in vivo animal imaging [4] . The long-term photostability and superior brightness of QDs make them appealing for live animal targeting and imaging. Additionally, recent studies have shown that QDs have two-photon action cross sections of magnitude larger than those of conventional fluorescent probes now in use, a further plus for deep tis-sue imaging [8] . In this paper, we will cover quantum dots optical properties, biological functionlization, in vitro diagnostics applications and in vivo animal imaging applications, and end with a discussion on the issues/limitations and future perspectives.
Optical properties of quantum dots
The classic and most commonly used quantum dots consist of a CdSe core and a shell layer made of ZnS or CdS. Fluorescence properties are determined by the core materials and the shell layer removes surface defects and prevents nonradiative decay, leading to a significant improvement in the particle stability and fluorescence quantum yields. For biological imaging applications, these hydrophobic dots can be made water soluble by exchanging with bifunctional ligands (mostly thiol or phosphine mono or multidentate ligands) or coating with amphiphilic polymers that contain both a hydrophobic segment or side chain (mostly hydrocarbons) and a hydrophilic segment or group (such as polyethylene glycol [PEG] or multiple carboxylate groups) Fig. 1a [3] . Additionally, biomolecules such as antibodies, peptides can be attached to the QDs to achieve specific labeling and targeting.
The novel optical property of QDs arises from the so-called "quantum confinement" effect of the semiconductor materials. This refers to the size-and composition-dependence of the semiconductor band gap energy. For nanocrystals smaller than the so-called Bohr excitation radius (a few nanometers), energy levels are quantized, with values directly related to the size of the nanoparticle. This dependence of light emission on the particle size allows the development of new fluorescence emitters with precisely tuned emission wavelengths (Fig. 1b) . For example, the semiconductor cadmium selenide (CdSe) has a bulk bandgap of 1.7 eV (corresponding to 730 nm light emission). QD of this material can be tuned to emit between 450-650 nm by changing the nanocrystal diameter from 2 to 7 nm. The composition of the material may also be used as a parameter to alter the bandgap of a semiconductor. QD with a diameter of 5 nm can be tuned to emit between 610-800 nm by changing the composition of the alloy CdSe x Te 1−x [9] . This property allows the production of virtually "unlimited" number of fluorophores using the same material.
Compared with organic dyes and fluorescent proteins, QDs have several advantages and unique applications. Firstly, QDs have very large molar extinction coefficients in the order of 0.5-5 × 10 [10] , about 10-50 times larger than that (5-10 × 10 4 M −1 cm −1 ) of organic dyes. Therefore, QDs are able to absorb 10-50 times more photons than organic dyes at the same excitation photon flux (that is, the number of incident photons per unit area), leading to a significant improvement in the probe brightness; making them brighter probes under photon-limited in vivo conditions (where light is severely attenuated by scattering and absorption). In theory, the lifetimelimited emission rates for single QDs are 5-10 times slower than those of single organic dyes because of their longer excited state lifetimes (20-50 ns) . In practice, however, fluorescence imaging usually operates under absorption-limited conditions, in which the rate of absorption is the main limiting factor of fluorescence emission (versus the emission rate of the fluorophore). As a result, individual QDs have been found to be 10-20 times brighter than organic dyes [11] . Secondly, QDs are several thousand times more resistant against photobleaching than organic dyes ( Figure 1d ) and are thus well-suited for continuous tracking studies over a long period of time. In addition, the longer excited state lifetimes of QDs can be used to separate the QD fluorescence from background fluorescence, in a technique known as time-domain imaging [12] ; since QDs emit light slowly enough that most of the background autofluorescence emission is over by the time QD emission occurs. Thirdly, the large Stokes shifts of QDs (measured by the distance between the excitation and emission peaks) can be used to further improve the detection sensitivity. The Stokes shifts of semiconductor QDs can be as large as 300-400 nm, depending on the wavelength of the excitation light. Organic dye signals with a small Stokes shift are often buried by strong tissue autofluorescence, whereas QD signals with a large Stokes shift are clearly detectable above the background. A further advantage of QDs is that multicolor QD probes can be used to image and track multiple molecular targets simultaneously. This feature is very desirable because most complex human diseases such as cancer and atherosclerosis involve a number of genes and proteins. Tracking a panel of molecular markers at the same time will lead to better understanding, classifying and differentiating complex human diseases than a single biomarker each time. Multiple parameter imaging, however, represents a significant challenge for magnetic resonance imaging, positron emission tomography, and computed X-ray tomography. By contrast, fluorescence optical imaging provides both signal intensity and wavelength information, and multiple wavelengths or colors can be resolved and imaged simultaneously (color imaging). In this regard, QD probes are particularly attractive, because their broad absorption profiles allow simultaneous excitation of multiple colors and their emission wavelengths can be continuously tuned by varying particle size and chemical composition. For organ and vascular imaging in which micrometer-sized particles could be used, optically encoded beads (polymer beads embedded with multicolor QDs at controlled ratios) could allow multiplexed molecular profiling in vivo at high sensitivities [13, 14] .
Biofunctionization
To make QDs more useful for molecular imaging and other biological applications, QDs need to be conjugated to biological molecules without disturbing the biological function of these molecules. Biomolecules including peptides, proteins and olgio nucleotides have been successfully linked to QDs. Several successful approaches have been used to link biological molecules to QDs, including non-specific adsorption, electrostatic interaction, mercapto (-SH) exchange, and covalent linkage (Fig. 2) [15] . Firstly, biological molecules containing thiol groups can be conjugated to the QD surface through a mercapto exchange process [16] [17] [18] [19] . Unfortunately, since the bond between Zn and thiol is not very strong and is dynamic. Biomolecules attached to QDs in this way can readily dissociate from the nanoparticle surface, causing QDs to precipitate from the solution.
It has also been reported that simple small molecules, such as oligonucleotides [20, 21] and various serum albumins [22] , are readily adsorbed to the surface of water soluble QDs. This adsorption is nonspecific and depends on ionic strength, pH, temperature, and the surface charge of the molecule. Mattoussi and coworkers presented a method of conjugating proteins to QD surfaces using electrostatic interactions. The protein of interest was engineered with a positively charged domain (poly histidine), which in turn interacted electrostatically with the negatively charged surface of dihydrolipoic acid (DHLA)-capped QD. The protein-QD conjugates prepared in this way were stable and the fluorescence quantum yield was even higher than that from the nonconjugated QDs [23] . Electrostatic interactions generally are not sufficiently specific, however, given the complexity of biological milieu. Therefore, conjugates made this way are not suitable for in vivo or ex vivo cell labeling due the possible interference from positively charged proteins.
A more stable linkage is obtained by covalently linking biomolecules to the functional groups on the QD surfaces using cross-linker molecules (Fig. 2) [7, [24] [25] [26] [27] . This method is the most commonly used approach for making biofunctionized QDs for in vitro cell labeling and in vivo imaging purposes. Most water solubilization methods result in QDs covered with carboxylic acid, amino or thiol groups. Under these situations, it is easy to link QDs to biological molecules which also have these functional groups. For example, the cross-linker 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) is commonly used to link -NH 2 and -COOH groups, whereas 4-(N-maleimidomethyl)-cyclohexanecarboxylic acid N-hydroxysuccinimide ester (SMCC) can be used to cross-link -SH and -NH 2 groups. Using these methods, there have been numerous reports of conjugating QDs with various biological molecules, including biotin [24] , oligonucleotides [28] , peptides [29] , and proteins including avidin/streptavidin [30] , albumin [3] , adaptor proteins (e.g. protein A, protein G) and antibodies [27, 30] . In addition, the native functional groups (-COOH, -NH 2 or -SH) on a water -soluble QD surface can be further converted to other functional groups to allow more versatile conjugation of QDs to biomolecules (site-specific conjugation, molecules that are sensitive to EDC or SMCC modification) (Fig. 2 ). For instance, carboxylic acids on QDs have been converted to hydrazides, allowing attachments of biomolecules containing sugar groups [27] . Recently, Zhang et al. presented another strategy for site-specific conjugation of biomolecules to QD surface [31] . This study utilized the specific and stable binding between HaloTag protein (HTP) and its ligand. QDs were first functionilized with HaloTag ligands, and the protein of interest (e.g Renilla luciferase, Lu8) was genetically fused to a HTP. When mixed together, QDs and Luc8 can be immobilized on QDs through the HTP-HaloTag ligands linkage. In most cases, the biological functions of these molecules have been preserved during the conjugation process.
In vitro diagnostic applications
Significant opportunities exist at the interface between biomarkers and nanotechnology for molecular cancer diagnosis. In particular, nanoparticle probes can be used to quantify a panel of biomarkers on intact cancer cells and tissue specimens, allowing a correlation of traditional histopathology and molecular signatures for the same material. A single nanoparticle is [11] ; b) Size-tunable emission spectra of QDs. This image shows ten distinguishable emission colors of ZnS-capped CdSe quantum dots excited with a near-UV lamp. From left to right (blue to red), the emission maxima are located at 443, 473, 481, 500, 518, 543, 565, 587, 610, and 655 nm [1] ; c) Excitation (dotted line) and fluorescence (solid line) spectra of fluorescein (top) and a typical water-soluble QD (bottom) [24] and d) Superior photostability of QDs as compared to organic dyes [30] . (Colors are visible in the online version: www.iospress.nl) large enough for conjugation to multiple ligands, leading to enhanced binding affinity and exquisite specificity through a "multivalency" effect. These features are especially important towards the analysis of cancer biomarkers that are present at low concentrations or in small numbers of cells. In this section, we will discuss some in vitro diagnostic applications of QDs as a fluorescent labeling agent.
The ability to study molecular and cellular events by using fluorescent probes has broadly impacted many areas in biomedical research including cell/molecular biology, drug screening, and molecular diagnostics. However, traditional fluorophores such as organic dyes and fluorescent proteins suffer from several intrinsic problems including rapid photobleaching, spectral cross-talking, narrow excitation profiles, and limited brightness/signal intensity. In contrast, the novel optical properties of QDs overcome many of the problems and offer new applications which are either difficult or impossible with traditional fluorophores. For instance, due to their broad excitation profiles and narrow/symmetric emission spectra, high-quality QDs are well suited for multiplexed tagging or encoding, in which multiple colors and intensities are combined to encode thousands of genes, proteins, or small-molecule compounds 3 [3] .
In vitro cell labeling
Wu et al. were among the first demonstrating that QDs can be used to specifically and effectively label molecular targets at the subcellular level [30] . In this study, QDs encapsulated within a polymer-shell were biofunctionized with molecules (streptavidin and im- Fig. 2 . Common methods used for the QD biofunctionization, including direct linkage to the TOPO coated QDs (Biomolecules can be linked include thiolated DNA (ligand exchange) or peptides with adhesive domains (see [4] for details), electrostatic interaction [23] , and covalent linking (see text for references).
munoglobulin) and applied to target cell surface receptor, cytoskeletal components (actin and microtubules) and nuclear antigen in both fixed and living cells. QDs of two different colors (630 nm and 535 nm) were used simultaneously and compared to an Alexa dye. Their results showed that QDs were considerably more photostable than the Alexa dye. Since then, QDbioconjugates (previously commercially available from Quantum dot corporation, now Invitrogen) have been used in a myriad of applications including in situ tissue profiling [27, 32] and fluorescent in situ hybridization applications [33] .
In situ tissue diagnostics
Diagnostic and prognostic classifications of human tumors are currently based on immunohistochemistry (IHC), a technique that has been used in clinical medicine for over 80 years [33] . However, the immunoenzyme -based IHC method has a single color nature and is incapable of multiplexed molecular profiling. The feature of multiplexing is becoming increasing important for cancer diagnosis since more and more studies are showing that a panel of biomarkers rather than a single one is needed to accurately determine the stage of the disease. Multiplexing has the advantage of reducing variability between tissue slices and is especially appealing in the case of precious specimens. The second issue with IHC is that it remains semi-quantitative and subjective, resulting in considerable inter-observer variation of the results. Immunofluorescence with organic fluorophores overcomes some of these problems (multiplexing, quantitative) but so far failed to prevail because of the poor photostability of these dyes. Moreover, multiplexed fluorescent labeling with conventional fluorophores is complicated with the need for a sophisticated laser system due to the non-ideal spectra properties of organic dyes. With the incorporation of QDs, quantitative and multiplexed fluorescent labeling becomes easy and handy. For instance, the simultaneous excitation of multiple colored QDs eliminates the need of a complex laser system and their superior photostability allows the samples to be stored and imaged many times for later analysis. Recognizing these advantages, several groups have successfully developed procedures for multiplexed fluorescent labeling of tissue specimens using QDs [27, [32] [33] [34] [35] . It is worth to note that in order for successful translation of QDs to clinical practice, it is important to gear the technology development toward real clinical specimens, the majority of which are archived, formalin fixed paraffinembedded tissues and might be several decades old. Since the clinical outcomes of these tissues are already known, it is of great value to use these specimens for examining the relationship between molecular profile and clinical outcome. Compared with cells or freshly harvested animal tissues, archived human specimens need special treatment such as harsher antigen retrieval (e.g. EDTA buffer (pH 8.0) vs. citrate buffer) and the incubation, and their background autofluorescence is generally stronger. It has been demonstrated that up to 5 biomarkers can be labeled and imaged simultaneously in the same tissue specimen [27, 32] . Combined with spectral analysis and automated image processing software, quantitative molecular profiling of clinical tissue specimens is likely to become the first clinical translation of QDs; since unlike in vivo imaging, in vitro profiling of tissue specimens do not face the problems such as toxicity and opsonization issues.
Although QDs have demonstrated great potential for in vitro tissue diagnostics and clinical translation seems not far away, several issues need to be solved in order for this technology to achieve widespread adaptation or significant clinical success. Firstly, systematic validation studies are urgently needed to verify the results from QDs labeling with conventional techniques such as western blotting and PCR. Some of the groups have already started and the initial results looked promising [33] . Secondly, more work on QD surface engineering and biofunctionization are needed to fully exploit the multiplexing potential of QDs for molecular profiling. This could include new conjugation chemistries that allow well-controlled bio-ligand orientation and the number of bio-ligands per nanoparticle and "friendly" chemistries which impart minimal detrimental effects to the ligand. For instance, the affinity of an antibody should not be significantly affected. Thirdly, the inclusion of housekeeping markers such as beta-actin or GAPDH is needed for standardization of the results and making the quantification more meaningful. Lastly, more studies are needed to establish robust protocols and experimental procedures to define the key factors and steps involved in QD immunohistochemical staining and data analysis. In particular, there are no consensuses on methods for QD-antibody (QD-Ab) bioconjugation, tissue specimen preparation, multicolor QD staining, image processing and data quantification [27] .
In addition to tissue diagnostics, there are also emerging applications of QDs for in vitro detection assays and many of them are fluorescence resonance energy transfer (FRET) based DNA hybridization applications [36] [37] [38] . In terms of detection sensitivity, QDs are less competitive than other nanoparticles such as the gold nanoparticle based bio-bar-codes developed by Mirkin and co-workers [39] . The unique advantage of QDs over other nanoparticles/nanostructures for in vitro detection assays is their multiplexing capability and the eventual winning diagnostic application will most likely to be the one that utilizes this feature such as the QD-tagged microbeads technology for DNA hybridization reported by Han et al. [14] .
In vivo imaging applications of quantum dots
While fluorescence imaging is often limited by the poor transmission of visible light through biological tissue, there is a near-infrared (NIR) optical window in most biological tissue that is suitable for deep-tissue optical imaging [40] . Only a few organic dyes emit brightly in this spectra region, and they suffer from photobleaching. On the contrary, the novel optical proper-ties of QDs allows the synthesis of bright and stable fluorescent labels that emit in the near-infrared spectrum by adjusting their size and composition [41] . Because visible QDs are more synthetically advanced, most animal imaging studies implementing quantum dots have used CdSe/ZnS QDs that emit visible light and a few recent studies started use near-infra red dots [41, 42] . Although still far from its mature stage, these studies have demonstrated the great performance and promise of QDs as fluorescent imaging agent in living animals.
Non-targeted animal imaging
Quantum dots have been used for non-targeted imaging in various animal models. Ballou and coworkers injected PEG-coated QDs into the mouse blood stream and investigated how the surface coating would affect their circulation lifetime [43] . In contrast to small organic dyes, which are eliminated from the circulation within minutes after injection, PEG-coated QDs were found to stay in the blood circulation for an extended period of time (half-life more than 3 h). This longcirculating feature is due to the relatively large size of PEG-coated QDs, which falls within an intermediate size range: they are small enough and sufficiently hydrophilic to slow down opsonization and reticuloendothelial uptake, but are large enough to avoid renal clearance. Amazingly, these QDs maintained their fluorescence even after four months in vivo. In 2003, Larson et al intravenously injected green QDs (550 nm) in a living mouse and visualized them dynamically through the skin (in capillaries hundreds of micrometers deep) by using two-photon microscopy ( Fig. 3a) [8] . In addition to the superior brightness and photostability, this study also found that QDs have two-photon excitation cross sections as high as 47,000 Goeppert-Mayer units, by far the largest of any label used in multiphoton microscopy. Two-photon excitation allows greater tissue penetration due to excitation within the NIR spectral range (e.g. 900 nm), but few fluorophores are bright enough for these purposes; QDs, with their large multiphoton excitation cross section, appear as ideal probes for multiphoton microscopy imaging.
Sentinel lymph node (SLN) SLN mapping is a technique that the assessment of nodal status for the spread of neoplasms. The underlying hypothesis of SLN mapping is that the first lying node to receive lymphatic drainage from a tumor site will contain tumor cells if there has been direct lymphatic spread. Conventional SLN mapping involved using a blue dye (for visualization of lymphatic vessels) and radioactive tracer to improve detection rate [44] . In 2004, Kim et al. [41] reported a non-invasive, real-time SLN mapping and resection by using near-infrared QDs. Advantages of this method arise from QD's novel optical properties including strong NIR fluorescence, superior photostability in body fluid and the relatively larger size (∼15 nm) which prevents leakage into neighboring regions and ensures retention of the particles in the SLNs. In this study, the authors prepared a novel core-shell nanostructure called type II QDs with fairly broad emission at 850 nm and a moderate quantum yield of ∼13%. In contrast to conventional QDs (type I), the shell materials in type II QDs have valence and conduction band energies both lower than those of the core materials. As a result, the electrons and holes are physically separated and the nanoparticles emit light at reduced energies (longer wavelengths). These NIR QDs made water soluble by oligomeric phosphine coating and injected intradermally in the left paw of a living mouse. Their results showed rapid uptake (5 min) of QDs into nearby lymph nodes and could be imaged virtually background-free (Fig. 3b) . The same study also demonstrated the feasibility of image-guided surgery in a big animal model. 400 pmole of NIR QDs injected intradermally permits sentinel lymph nodes 1 cm deep to be imaged easily in real time (and removed surgically) using excitation fluorescence rates of only 5 mW/cm 2 . The versatility of this technique was further proven by successful applications for SLN mapping in the lung and the gastrointestinal tract [44] .
QDs have also been used for cell tracking studies [11, [45] [46] [47] [48] . QDs were delivered into live mammalian cells via three different mechanisms: non-specific pinocytosis, microinjection, and peptide-induced transport (e.g. using the protein transduction domain of HIV-1 Tat peptide, Tat-PTD) [49] . A surprising finding was that two billions of QDs could be delivered into the nucleus of a single cell, without compromising its viability, proliferation or migration [45, 47, 49] . The ability to image single-cell migration and differentiation in real time is expected to be important to several research areas such as embryogenesis, cancer metastasis, stem-cell therapeutics and lymphocyte immunology. These studies demonstrated the potential of using QDs to track cell, tissue, and organ developments over extended periods of time, a task not possible with small molecule organic dyes with fast photobleaching.
Targeted in vivo imaging
The above studies demonstrated the capability of QDs for living animal imaging, but have only demon- Fig. 3 . Animal imaging applications using quantum dots. a) Two-photon fluorescence imaging of capillaries at the base of the dermis with QD (1 µM) (top) and fluorescein (40 µM) (bottom) intravenously delivered to the animal (adapted from [8] ). b) NIR QD fluorescence guided dissection of a lymph node in a pig. 400 pmol of NIR QDs were injected intradermally in the right groin [41] . c) Targeted tumor imaging using quantum dots antibody conjugates [11] . d) Tumor imaging using QD705 RGD bioconjugates [42] . strated image contrast at the tissue/organ level. The goal of molecular imaging is to generate image contrast due to the molecular difference in different tissues and organs. This requires a probe that has a targeting moiety to generate contrast only in locations specified by the targeting probe. Akerman et al. were among the first to explore the possibility of using QD-peptide conjugates to target tumor vasculatures in-vivo [19] . QDs coated with peptides targeting the lung-vasculature, blood vessel and tumor cell, or lymphatic vessels were injected systematically into mouse. Although they were not able to image the QDs in living animal, histological sections of different organs after 5 or 20 min of circulation revealed that QDs homed to tumor vessels guided by the peptides, but not to surrounding tissues, probably due to their larger size relative to organic dyes (which would stain surrounding tissues). Whole animal imaging of molecular-level detection was realized by Gao et al. in 2004 using red fluorescent QDs conjugated to antibodies specific to prostate-specific membrane antigen (PSMA) on a human prostate cancer induced in a mouse [11] . QD conjugates used in this study contained an amphiphilic triblock copolymer for in vivo protection, targeting ligands (anti-PSMA) for tumor antigen recognition, and multiple PEG molecules for improved biocompatibility and circulation. The QDtagged PSMA antibodies recognized and bound at the tumor site and were clearly imaged in vivo (Fig. 3c) . Controls experiments with QD-PEG (no targeting ligand) or QD only confirmed the binding was specific and the accumulation of non-targeted QDs at tumor sites was marginal compared with the targeted ones. There are two possible mechanisms for the preferential accumulation of QDs at tumor sites: passive targeting due to the enhanced permeability and retention (EPR) effect and active targeting because of the antibody, PS-MA, which is a cell surface marker for both prostate epithelial cells and neovascular endothelial cells. Because the QDs emit in the visible range, a spectral unmixing algorithm was used to separate QD signal from background autofluorescence. More recently, Cai et al used near-infrared QDs for tumor imaging by targeting angiogenesis, the formation of new blood vessels from preexisting vasculture [42] . Amine-modified QD705 (emission maximum at 705 nm) were conjugated to α v β 3 integrin targeting cyclic RGD peptide and injected intravenously into living mice. Tumor fluorescence reached maximum at 6 hr post injection with good contrast (Fig. 3d) . Since angiogenesis is common to all tumors, this technique may aid cancer detection and management in general. It is worth to note that in both studies, a significant portion of the injected QDs went to the RES system, including the liver, spleen and lung.
In vivo imaging using self-illuminating quantum dots
Self-illuminating quantum dots (also known as QD-BRET conjugates) are a class of new QDs that do not require external excitation light to fluoresce, instead, energy comes from a bioluminescence protein through non-radiative energy transfer from a neighboring bioluminescenct proteins. Bioluminescence resonance energy transfer (BRET) is a naturally occurring phenomenon whereby a light-emitting protein (the donor, e.g. R. reniformis luciferase) non-radiatively transfers energy to a fluorescent protein (the acceptor, e.g. GFP) in close proximity. BRET is analogous to FRET except that the energy comes from a chemical reaction catalyzed by the donor enzyme (e.g. R. reniformis luciferase-mediated oxidation of its substrate coelentrazine) rather than absorption of excitation photons. Compared to fluorescence imaging, bioluminescence has extremely high sensitivity for in vivo imaging purposes [50] . Recently, work in the Rao lab has demonstrated the feasibility of using QDs as the acceptor in a bioluminescence resonance energy transfer system [51] . In this study, QDs were covalently conjugated by to the donor, Luc8 protein, an eight-mutation variant of the bioluminescence R. reniformis luciferase [52] . The protein emits blue light with a peak at 480 nm upon the addition of substrate, coelentrazine. If a QD is in close proximity of the protein, it can be excited and emit at its emission maximum (Fig. 4) . The advantage of using bioluminescence versus fluorescence lies in the fact that no external excitation is needed. This "self-illuminating" feature allows cancer imaging in deeper tissue where light is limited. Since no excitation light is needed, the autofluorescence problem is automatically solved. In addition, since this coupling method is generic, any QDs with carboxyl groups (including those emits in the NIR region, e.g. 705, 800 nm QDs have been tested) can be used as a BRET receptor and therefore allows for multiplexed imaging. Compared with existing QDs, self-illuminating QD conjugates have greatly enhanced sensitivity in small animal imaging, with an in vivo signal-to-background ratio of >1000 for 5 pmole of conjugates subcutaneously injected. One critical issue in making these self-emitting QDs is the size of the nanoparticle, since like FRET, BRET is also a distance-sensitive process. Increase in the QD conjugate size results in greater distance between the protein and the fluorescent semiconductor core, and thereby decreases the energy transfer efficiency significantly. For instance, the authors have observed that increasing the protein-nanoparticle distance by only 2-3 nm causes the BRET ratio to drop from 1.29 to 0.37 [51] . By attaching targeting moieties such as tumor homing antibodies or peptides to the BRET assembly, it is possible to use BRET QDs for targeted tumor imaging in living animals.
More recently, QD-BRET was successfully applied to proteolytic activity detection in buffer with a slightly different coupling scheme [53] . In this study, a 15 amino acid peptide (GGPLGVRGGHHHHHH), containing the MMP-2 substrate and a six-histidine tag, was genetically fused to the C terminus of the BRET donor, Luc8. In the presence of Ni 2+ cations, the carboxylic acids on the QDs will bind the metal ions and form complexes with the 6 x His tag on the Luc8 fusion protein. BRET will take place and produce light emission from the QDs. The cleavage of the amide bond between Gly and Val by MMP-2 will release the 6 x His tag from the fusion Luc8 and thus no BRET will occur. In the presence of active MMP-2, the protein is released from the conjugates and BRET did not happen. Similar concept can be applied for in vivo protease detection and imaging with a different coupling strategy which ensures site-specific conjugation (so that protease substrate positioned between QD and Luc8) and meanwhile makes the conjugates stable and resistant from interference from other proteins present inside living body.
Future perspectives
Although QDs provide a class of exciting new fluorescent probes that opens up a lot opportunities for fluorescence imaging, several issues remain and need to be resolved before QDs can be widely used for targeted imaging of tumor or other diseases in human subjects. Some of these issues are applicable to all nanostructures intended for molecular imaging purposes.
Due to their superior photostability and highly brightness, QDs have been tested for in vivo imaging applications from early on. Regardless of tremendous interests and initial successes, the progress in recent years is rather slow. This lack of breakthroughs reflects the nature of challenges in this aspect. In the rest of this section, we will go over each of the challenges and point out some future directions. 
RES uptake and blood circulation
The first issue is their relatively short circulation half-life, preventing long-term imaging or cell tracking studies. Literature on the in vivo studies using QDs for imaging have revealed that their circulation halftime is influenced strongly by the surface chemistry and that they are cleared from the circulation primarily by phagocytosis of the nanoparticle by RES in the liver spleen and lymph nodes [11, 43] . Coating with PEG increases the circulation half-life, and attachment to targeting moieties (such as antibodies) reduces the dose needed to generate contrast between normal and tumor tissue [11] . Even with these strategies incorporated, the majority of nanoparticles still end up in the reticuloendothelial system (RES). A recent study using commercial non-targeted amino (PEG) QD705 for imaging glioma in rat suggested that maximal RES phagocytosis of QDs was reached between 3.4-and 8.5 nmole doses [54] . Significant tumor uptake of QDs was observed for doses higher than 8.5 nmole. Such a high dose might pose health hazard to the living subjects. Therefore, there is an urgent need for engineering strategies to improve the circulation half-time of QDs, since the longer they can stay in the circulation system the better chances are that they may be able to get to the tumor site. This might be achieved by minimizing the opsonization or other components of the RES, and a few groups have started studying on the interaction between blood components and nanoparticles in order to attack this problem [55, 56] . The rationale is that nanoparticles, once entered the blood stream, are immediately covered by plasma proteins; what the RES system "sees" and what defines the identity of the nanoparticle is largely the protein corona around the particle, not the core material. Elucidation of the profiles of adsorbed proteins on nanoparticles has the potential to facilitate engineering a surface chemistry that is less prone to opsonization and RES uptake. The alternative approach is to make smaller QDs that completely evade the RES system. A recent study by Frangioni laboratory [57] has shown that QDs with a hydrodynamic size of 5.5 nm or smaller can evade the RES organs (no accumulation in the liver, spleen or lung) and be cleared by the renal system. QDs used in this study were cysteine-coated [58] with no targeting or other biofunctional groups, therefore it remains a challenge, how to make biofunctionized QDs while keeping the size below 5.5 nm.
High quality NIR dots for deeper tissue penetration
Although the superior brightness and photostability of QDs made them attractive candidates for in vivo animal imaging, most of the current QDs still emit within the visible range. The ideal QDs for deep tissue imaging, that is, high-quality QDs with near-infraredemitting properties are not yet widely available. Recent developments include a promising water-based synthesis method that yields particles that emit from the visible to the NIR spectrum and are intrinsically water soluble, but the particles have yet to be tested in biological [59] environments. Most materials (e.g. PdS, PdSe, CdHgTe and CdSeTe) are either not bright or not stable enough for biomedical imaging applications. As such, there is an urgent need to develop bright and stable near-infrared-emitting QDs that are broadly tunable in the far-red and infrared spectral regions [11] . Theoretical modeling studies by Lim et al. [60] indicate that two spectral windows are excellent for in vivo QD imaging, one at 700-900 nm and another at 1200-1600 nm. In addition to high quality NIR QDs, multiphoton fluorescence microscopy and novel illuminating mechanisms such as bioluminescence energy transfer can all be used to achieve deeper tissue penetration.
Toxicity
One of the major issues that hinder the application of QDs to human subjects is the concern about their safety: cadmium and selenium are potential hazard for neurological and genitourinary toxicity. Indeed, in vivo toxicity is likely to be a key factor in determining whether QD imaging probes would be approved by regulatory agencies for human clinical use. Cell culture studies [61] indicate that CdSe QDs are highly toxic to cultured cells under UV illumination for extended periods of time. This is not surprising because the energy of UV irradiation is close to that of a covalent chemical bond and dissolves the semiconductor particles in a process known as photolysis, releasing toxic cadmium ions into the culture medium. In the absence of UV irradiation, QDs with a stable polymer coating are not likely to be toxic to cells and animals. In vivo studies by Ballou and coworkers also confirmed the nontoxic nature of stably protected QDs [43] . Still, there is an urgent need to systematically study the cellular toxicity and in vivo degradation mechanisms of QD probes. For polymer-encapsulated QDs, chemical or enzymatic degradation of the semiconductor cores is unlikely to occur. The polymer-protected QDs might be cleared from the body by slow filtration and excretion out of the body. This and other possible mechanisms must be carefully examined before any human applications in tumor or vascular molecular imaging. While modifications of QD surfaces can help QDs cleared from the body within a reasonable time frane, an alternative is to will be more difficult to replace the toxic elements of QDs while retaining replace the toxic elements of QDs but retain similare optical properties (e.g. high quantum yield, stability) [15] .
Perspectives
Quantum dots as a novel fluorescent probes have proved to be tremendous useful in many areas of biological and medical research, especially multiplexed tissue/cell labeling, live cell imaging as well as in vivo imaging. However, as an in vivo imaging agent, QDs are still at a very premature stage. Several issues (including toxicity, size issue and clearance by RES) remain before its potential can be fully exploited and applied to human subjects. Although the performances of visible QDs are greatly improved than conventional fluorophores, an ideal QD fluorophore should emit in the near-infrared/far red region with high quantum yield and excellent stability. Meanwhile, techniques such as two-photon excitation [8] can be used to facilitate the use of visible dots for better tissue penetration. In summary, quantum dots technology for in vivo cancer imaging is still an area of active research and its further development will benefit from the collaboration of chemists, biologists and material scientists.
